{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:55:50Z","timestamp":1784876150439,"version":"3.55.0"},"reference-count":20,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Atrial septal defect (ASD) is a prevalent congenital heart condition, resulting in left-to-right shunting. Untreated ASDs may be associated with complications, including right-sided heart failure, pulmonary hypertension, and atrial arrhythmias. Percutaneous ASD closure, performed with various occluder devices, has become the preferred approach for symptomatic patients with suitable anatomy, yet data on device-specific efficacy and safety profiles remain limited. Methods: This study was a retrospective, single-center analysis involving patients who underwent percutaneous ASD closure between January 2000 and February 2023. Data on patient characteristics, indications for the procedure, procedural details, and clinical outcomes were extracted from electronic medical records. Endpoints included complications at the puncture site, pericardial effusion, atrial arrhythmias, device-related thrombus formation, and overall survival. Results: A total of 195 patients were included (mean age 53.6 \u00b1 16.2 years; 60.5% female). Three different devices were used: Amplatzer ASD occluder (n = 111), Gore Septal Occluder (n = 67), and Occlutech ASD occluder (n = 17). Initial procedural success rate was 90.8%, with no significant differences observed between devices. Periprocedural complication rates were low and comparable across all devices. New-onset atrial fibrillation within the first month post-implantation occurred in 7.5% of patients with the Gore device, compared to 0.9% with the Amplatzer device (p = 0.03) and 0% with the Occlutech device. No statistically significant differences were observed among the devices regarding thrombus formation, late-onset pericardial effusion, device erosion, or stroke. Conclusions: Percutaneous ASD closure demonstrates high procedural success and low complication rates across different occluder devices, supporting its efficacy and safety as a treatment for adults. Although the Gore device showed a higher incidence of new-onset AF compared to the Amplatzer device, no significant differences were observed regarding thrombus formation, pericardial effusion, device erosion or stroke.<\/jats:p>","DOI":"10.3390\/jcm14061867","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:02:59Z","timestamp":1741608179000},"page":"1867","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and Safety of Percutaneous ASD Closure in Adults: Comparative Outcomes of Occluder Devices in a Single-Center Cohort"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-2825","authenticated-orcid":false,"given":"Elham","family":"Kayvanpour","sequence":"first","affiliation":[{"name":"Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg\/Mannheim, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Matzeit","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2683-1369","authenticated-orcid":false,"given":"Christoph","family":"Reich","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg\/Mannheim, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3745-0836","authenticated-orcid":false,"given":"Ziya","family":"Kaya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg\/Mannheim, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Pleger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Frey","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg\/Mannheim, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Meder","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg\/Mannheim, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3266-0527","authenticated-orcid":false,"given":"Farbod","family":"Sedaghat-Hamedani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Heidelberg University, 69120 Heidelberg, Germany"},{"name":"DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg\/Mannheim, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/01.CIR.37.5.805","article-title":"Natural history and prognosis of atrial septal defect","volume":"37","author":"Craig","year":"1968","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/CIRCULATIONAHA.105.592055","article-title":"Atrial septal defects in the adult: Recent progress and overview","volume":"114","author":"Webb","year":"2006","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/eurheartj\/ehq249","article-title":"ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)","volume":"31","author":"Baumgartner","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1093\/eurheartj\/ehab646","article-title":"Atrial septal defect in adulthood: A new paradigm for congenital heart disease","volume":"43","author":"Brida","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.acvd.2022.09.002","article-title":"Comparative effectiveness of devices for transcatheter closure of atrial septal defects: Systematic review and network meta-analysis","volume":"115","author":"Vishwanath","year":"2022","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2169\/internalmedicine.6946-20","article-title":"Transcatheter Closure of an Atrial Septal Defect","volume":"61","author":"Ueda","year":"2022","journal-title":"Intern. Med."},{"key":"ref_7","first-page":"e40132","article-title":"Transcatheter Closure of Atrial Septal Defect: A Review of Currently Used Devices","volume":"15","author":"Shrivastava","year":"2023","journal-title":"Cureus"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jcin.2009.12.011","article-title":"The impact of transcatheter atrial septal defect closure in the older population: A prospective study","volume":"3","author":"Khan","year":"2010","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e034249","DOI":"10.1161\/JAHA.124.034249","article-title":"Atrial Fibrillation After Patent Foramen Ovale Closure: Incidence, Pathophysiology, and Management","volume":"13","author":"Apostolos","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/ccd.22172","article-title":"New onset atrial fibrillation after patent foramen ovale closure","volume":"74","author":"Staubach","year":"2009","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00392-021-01964-2","article-title":"Device-related risk of atrial fibrillation after closure of patent foramen ovale: A systematic review and meta-analysis","volume":"111","author":"Vukadinovic","year":"2022","journal-title":"Clin. Res. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s00380-020-01739-1","article-title":"Efficacy and safety of atrial septal defect closure using Occlutech Figulla Flex II compared with Amplatzer Septal Occluder","volume":"36","author":"Nakayama","year":"2021","journal-title":"Heart Vessels"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.4244\/EIJ-D-18-01016","article-title":"Prospective concurrent head-to head comparison of three different types of nitinol occluder device for transcatheter closure of secundum atrial septal defects","volume":"15","author":"Bhattacharjya","year":"2019","journal-title":"EuroIntervention"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ahj.2016.03.022","article-title":"Contributors to and impact of residual shunting after device closure of atrial septal defects","volume":"177","author":"Zdradzinski","year":"2016","journal-title":"Am. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ccd.24347","article-title":"Percutaneous atrial septal occluder devices and cardiac erosion: A review of the literature","volume":"80","author":"Crawford","year":"2012","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_16","first-page":"11","article-title":"State-of-the-Art Atrial Septal Defect Closure Devices for Congenital Heart","volume":"8","author":"Levi","year":"2019","journal-title":"Interv. Cardiol. Clin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.jtcvs.2009.02.032","article-title":"Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database","volume":"137","author":"DiBardino","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"100058","DOI":"10.1016\/j.ijcchd.2020.100058","article-title":"Transcatheter closure of atrial septal defect in the elderly: Early outcomes and mid-term follow-up","volume":"1","author":"Giordano","year":"2020","journal-title":"Int. J. Cardiol. Congenit. Heart Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.cjca.2011.04.003","article-title":"Atrial septal defect closure in the elderly is associated with excellent quality of life, functional improvement, and ventricular remodelling","volume":"27","author":"Hanninen","year":"2011","journal-title":"Can. J. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kayvanpour, E., Matzeit, E., Kaya, Z., Pleger, S., Bahrmann, A., Reichardt, C., Ringleb, P.A., Frey, N., Meder, B., and Sedaghat-Hamedani, F. (2024). Comparative Effectiveness of Devices for Interventional Patent Foramen Ovale Closure: Insights from a 23-Year Monocentric Analysis. J. Clin. Med., 13.","DOI":"10.3390\/jcm13216354"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/6\/1867\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:50:12Z","timestamp":1760028612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/6\/1867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["jcm14061867"],"URL":"https:\/\/doi.org\/10.3390\/jcm14061867","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]}}}